Augmedics' Xvision spine system was used in its 2,000th case.

Aurora Spine's quarterly revenue continued 2022 growth in the second quarter, and the company is laying the groundwork for momentum into 2023.

Aurora Spine saw record sales in the second quarter of 2022, the devicemaker said Aug. 29.

Medtronic executives said in the company's Aug. 23 earnings call that its cranial and spinal technologies business "remains attractive" despite revenue decreasing 7 percent year over year in the first quarter of fiscal year 2023, according to Seeking Alpha.

Nexus Spine's leadership appointment and five more key updates from medtech companies since Aug. 17.

Xtant Medical entered an agreement to sell common stock and warrants to investors.

Surgalign's Cortera spinal fixation system received FDA 510(k) clearance, the devicemaker said Aug. 24.

Spineology named Jamison Young CFO, the devicemaker said Aug. 23.

Abbott's Proclaim Plus spinal cord stimulator received FDA approval.

Nexus Spine's PressON posterior lumbar fixation system was launched, the devicemaker said Aug. 23.

Medtronic saw $7.4 billion in revenue in the first quarter of fiscal year 2023, according to results posted Aug. 23.

Theragen's ActaStim-S spine fusion bone growth stimulator system received a U.S. patent.

Zavation Medical Products' Varisync system received FDA 510(k) clearance.

VySpine's VyPlate anterior cervical plate system received FDA 510(k) clearance, the devicemaker said Aug. 16.

Accelus reaches a milestone with a new implant and three more updates from spine devicemakers since Aug. 10:

Intraoperative neuromonitoring company Assure Holdings saw its second quarter 2022 managed case volume jump by about 36 percent year-over-year.

Accelus has announced the first spinal surgeries using its minimally invasive TiHawk11 Interbody Fusion System. 

Globus Medical, Smith+Nephew and ZimVie shared their second-quarter results. Of those three companies, one reported a year-over-year increase in revenue.

Stryker, Johnson & Johnson and Zimmer Biomet all saw year-over-year total revenue increases during the second quarter, but their spine and orthopedic sales varied in growth.

Max Reinhardt has been elected to the board of directors at Sure Retractors, a medical device company specializing in spinal surgery solutions.